TrialJournal of clinical pharmacology2026

Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.